Galectin Therapeutics Inc. (GALT)

[HankVerde]

Traber is an indispensable asset in his own eyes and in those of his buddies whom he's enriched, but he's done nothing to enhance shareholder value (unless you consider dropping the share price from over $19 to $1 as enhancing shareholder value). So, my answer is NO!

Imagine the cash bonuses management will vote themselves if anything ever does get approved! Enriching themselves at the expense of the shareholders is Traber's game and if something good happens well, so much the better, but management is grabbing what they can while there is still cash in the bank. He's counting on the richer investors to keep finding his personal pot of gold so as not to lose the fortunes they've already committed, and so far it's working.

At another company I'm invested in the CEO takes all of his compensation in stock at current prices, no options at a discount. He's also invested millions of his own money buying stock in the market. He believes in the future of the company's products, which are in FDA trials and review. I've been a GALT shareholder (and all of its predecessors) since 2003 (yes, I know, a gluten for punishment), and I've never seen that kind of commitment from any GALT management team. And this one is the worst. A change is due!

Good luck to all shareholders, especially the tired ones like me.